Was it the drug, Vascepa, that prevented cardiac deaths? Or was part of the result due to a placebo that wasn’t? ““Is this a one-off chance finding, or is it a drug that is an amazing addition to our armamentarium?”
Was it the drug, Vascepa, that prevented cardiac deaths? Or was part of the result due to a placebo that wasn’t? ““Is this a one-off chance finding, or is it a drug that is an amazing addition to our armamentarium?”
In his last public interview before leaving Geisinger Health for Google, Dr. Feinberg appeared on the monthly podcast ‘Fixing Healthcare.’ Using his comments and my research as background, here are five healthcare opportunities Google might pursue.
CityMD has a new ad campaign out and it’s interesting. One, it’s entertaining. Two, it’s insightful in its use of perspective. In this case putting the viewers in the “sick-seat” so we can experience all the social awkwardness of our friends and family…
AI relates often imperceptible observations to outcome in a fashion that’s unapologetically oblivious to mechanism, which challenges physicians and drug developers by explicitly severing utility from foundational scientific understanding.
The US is losing the AI to China. Immediate strategic and tactical steps must be made to turn the tide of the war. Investments, organizational changes and a “moonshot mentality” is necessary to win this existential technology war, including the appoi…